• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.44% Nasdaq Down0.42%

    Lixte Biotechnology Holdings, Inc. (LIXT)

    -Other OTC
    0.30 Up 0.04(13.46%) 3:55PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Lixte Biotechnology Holdings, Inc.
    248 Route 25A, No. 2
    East Setauket, NY 11733
    United States - Map
    Phone: 631-942-7959
    Website: http://www.lixte.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Lixte Biotechnology Holdings, Inc., a development stage company, researches and develops treatments for human cancers and other common non-malignant diseases. It develops anti-cancer drugs for life-threatening diseases using biomarker technology. The company focuses on the development of protein phosphatase inhibitors, such as the LB-100 series of compounds; and histone deacetylase inhibitors, including the LB-200 series of compounds for the treatment of cancer, as well as in the prevention and treatment of neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in East Setauket, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Lixte Biotechnology Holdings, Inc.

    Key Executives 
    Dr. John S. Kovach M.D., 78
    Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Principal Accounting Officer
    Mr. Gil N. Schwartzberg Esq.,
    Dr. Francis Johnson Ph.D.,
    Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders